" /> Bile acid synthesis defect, congenital, 1 - CISMeF





Preferred Label : Bile acid synthesis defect, congenital, 1;

Symbol : CBAS1;

CISMeF acronym : CBAS1;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : 3-beta-hydroxy-delta-5-c27-steroid oxidoreductase deficiency;

Description : Congenital defects of bile acid synthesis are autosomal recessive disorders characterized by neonatal onset of progressive liver disease with cholestatic jaundice and malabsorption of lipids and lipid-soluble vitamins from the gastrointestinal tract resulting from a primary failure to synthesize bile acids. Affected infants show failure to thrive and secondary coagulopathy. In most forms of the disorder, there is a favorable response to oral bile acid therapy (summary by Cheng et al., 2003). - Genetic Heterogeneity of Congenital Defects in Bile Acid Synthesis There are several disorders that result from defects in bile acid synthesis. See CBAS2 (235555), caused by mutation in the delta(4)-3-oxosteroid 5-beta-reductase gene (AKR1D1; 604741) on chromosome 7q32; CBAS3 (613812), caused by mutation in the 7-alpha hydroxylase gene (CYP7B1; 603711) on chromosome 8q21; and CBAS4 (214950), caused by mutation in the AMACR gene (604489) on chromosome 5. See also progressive familial intrahepatic cholestasis (PFIC1; 211600), which has a similar phenotype.;

Inheritance : Autosomal recessive;

Molecular basis : Caused by mutation in the 3-beta-hydroxy-delta-5-C27-steroid oxidoreductase gene (HSD3B7, 607764.0001);

Laboratory abnormalities : Increased serum bilirubin; Abnormal liver function tests; Decreased serum cholesterol; Normal serum levels of gamma-GGT (231950);

Prefixed ID : #607765;

Details


You can consult :


Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.